Skip to main content
graph.swiss
Johnson & Johnson

Johnson & Johnson

202.30 CHF-1.95 (-0.95%)
XSWX:JNJMarket Closed
ListedCHF487.0BHealthcareDrug Manufacturers - General138,200 employees

Company Profile

Legal NameJohnson & Johnson
CEOMr. Joaquin Duato
HeadquartersOne Johnson & Johnson Plaza
Phone732 524 0400
Employees (FTE)138,200
SectorHealthcare
IndustryDrug Manufacturers - General

Other Listings & Derivatives(1)

Business Description

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience, cardiovascular and metabolic disorders, and pulmonary hypertension; and MedTech, which provides advanced surgical equipment, devices for orthopaedics, vision care, and solutions for robotics, navigation, and digital technologies. The company delivers innovative medicines and medical technologies that address unmet patient needs across diverse therapeutic areas, supporting healthcare professionals and consumers globally. Johnson & Johnson plays a pivotal role in the healthcare sector by advancing medical innovation and improving health outcomes through its broad portfolio of branded products and services. Founded in 1887 and headquartered in New Brunswick, New Jersey, it remains a cornerstone of the global health technology and pharmaceuticals industry.

Profitability & Growth

Profitability

Profit Margin+21.48%
Operating Margin+28.34%
Return on Equity (TTM)+32.87%
Return on Assets (TTM)+13.46%

Recent Year-End

Revenue79.18B
Revenue / Share40.51
Gross Profit53.92B
EBITDA35.16B
Diluted EPS6.94
Earnings Growth YoY-0.10%
Revenue Growth YoY+6.60%

Balance Sheet Snapshot

Total Cash (MRQ)

3.31B

Total Debt (MRQ)

54.99B

Current Ratio (MRQ)

1.03

Book Value / Share

27.31

Stock Statistics

Shares Outstanding2.41B
Float Shares2.41B
Avg Volume (10d)5
Avg Volume (90d)2
% Held by Insiders+0.05%
% Held by Institutions+76.89%

Valuation

Market Cap486.98B
Enterprise Value515.20B
Trailing P/E26.09
PEG Ratio-360.43
Price / Sales (TTM)4.45
Price / Book (MRQ)6.63
EV / Revenue5.47
EV / EBITDA14.65

Price Summary

52-Week Low172.65
52-Week High215.60
50-Day MA189.37
200-Day MA187.13

Dividends

Forward Div Rate4.33
Forward Div Yield+2.14%
Trailing Div Rate2.13
5Y Avg Div Yield+254.00%
Payout Ratio+30.63%
Ex-Dividend Date2026-08-25